Development of Symptomatic Bone Marrow Metastasis After Complete Response to Immunochemotherapy in Squamous Cell Lung Carcinoma

Recurrence presenting bone marrow metastasis should be considered in patients with squamous cell lung cancer, even achieving complete response to immunochemotherapy, particularly those with bone metastases.

Authors

Institutions

Publication Details

Journal
Cancer Reports
Published
2025-11-28
DOI
https://doi.org/10.1002/cnr2.70385
Primary Topic
Hematological disorders and diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of Symptomatic Bone Marrow Metastasis After Complete Response to Immunochemotherapy in Squamous Cell Lung Carcinoma

Nami Kitagawa, Hideaki Hamano, Maki Ohya, Hajime Midorikawa et al.
Cancer Reports
Hematological disorders and diagnostics
article

Development of Symptomatic Bone Marrow Metastasis After Complete Response to Immunochemotherapy in Squamous Cell Lung Carcinoma

Nami Kitagawa, Hideaki Hamano, Maki Ohya, Hajime Midorikawa, Tomonobu Koizumi, Reoto Takei, Fumihiro Kawakami, Yoshinori WAKI, Akari Momose
article en

Abstract

Recurrence presenting bone marrow metastasis should be considered in patients with squamous cell lung cancer, even achieving complete response to immunochemotherapy, particularly those with bone metastases.

Cancer ReportsVol. 8(12)
Shinshu University (JP), Nagano Prefectural College (JP), Shinshu University Hospital (JP)
Openalex Percentile: Top 47%
Hematological disorders and diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.